284 related articles for article (PubMed ID: 21151607)
1. Molecular interactions between prions as seeds and recombinant prion proteins as substrates resemble the biological interspecies barrier in vitro.
Panza G; Luers L; Stöhr J; Nagel-Steger L; Weiss J; Riesner D; Willbold D; Birkmann E
PLoS One; 2010 Dec; 5(12):e14283. PubMed ID: 21151607
[TBL] [Abstract][Full Text] [Related]
2. Seeded fibrillation as molecular basis of the species barrier in human prion diseases.
Luers L; Bannach O; Stöhr J; Wördehoff MM; Wolff M; Nagel-Steger L; Riesner D; Willbold D; Birkmann E
PLoS One; 2013; 8(8):e72623. PubMed ID: 23977331
[TBL] [Abstract][Full Text] [Related]
3. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
4. Genetic and infectious prion diseases.
Prusiner SB
Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
[TBL] [Abstract][Full Text] [Related]
5. Aggregation and amyloid fibril formation of the prion protein is accelerated in the presence of glycogen.
Panza G; Stöhr J; Birkmann E; Riesner D; Willbold D; Baba O; Terashima T; Dumpitak C
Rejuvenation Res; 2008 Apr; 11(2):365-9. PubMed ID: 18341429
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous and BSE-prion-seeded amyloid formation of full length recombinant bovine prion protein.
Panza G; Stöhr J; Dumpitak C; Papathanassiou D; Weiss J; Riesner D; Willbold D; Birkmann E
Biochem Biophys Res Commun; 2008 Sep; 373(4):493-7. PubMed ID: 18585368
[TBL] [Abstract][Full Text] [Related]
7.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
8. Species-barrier phenomenon in prion transmissibility from a viewpoint of protein science.
Hagiwara K; Hara H; Hanada K
J Biochem; 2013 Feb; 153(2):139-45. PubMed ID: 23284000
[TBL] [Abstract][Full Text] [Related]
9. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
10. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
11. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
[TBL] [Abstract][Full Text] [Related]
12. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
[TBL] [Abstract][Full Text] [Related]
13. Prion transmission prevented by modifying the β2-α2 loop structure of host PrPC.
Kurt TD; Bett C; Fernández-Borges N; Joshi-Barr S; Hornemann S; Rülicke T; Castilla J; Wüthrich K; Aguzzi A; Sigurdson CJ
J Neurosci; 2014 Jan; 34(3):1022-7. PubMed ID: 24431459
[TBL] [Abstract][Full Text] [Related]
14. Neurotoxicity but not infectivity of prion proteins can be induced reversibly in vitro.
Post K; Brown DR; Groschup M; Kretzschmar HA; Riesner D
Arch Virol Suppl; 2000; (16):265-73. PubMed ID: 11214930
[TBL] [Abstract][Full Text] [Related]
15. Seeding specificity and ultrastructural characteristics of infectious recombinant prions.
Piro JR; Wang F; Walsh DJ; Rees JR; Ma J; Supattapone S
Biochemistry; 2011 Aug; 50(33):7111-6. PubMed ID: 21776987
[TBL] [Abstract][Full Text] [Related]
16. Transgenic models of prion disease.
Scott MR; Supattapone S; Nguyen HO; DeArmond SJ; Prusiner SB
Arch Virol Suppl; 2000; (16):113-24. PubMed ID: 11214913
[TBL] [Abstract][Full Text] [Related]
17. Insights into the Bidirectional Properties of the Sheep-Deer Prion Transmission Barrier.
Harrathi C; Fernández-Borges N; Eraña H; Elezgarai SR; Venegas V; Charco JM; Castilla J
Mol Neurobiol; 2019 Aug; 56(8):5287-5303. PubMed ID: 30592012
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods.
Shaked GM; Meiner Z; Avraham I; Taraboulos A; Gabizon R
J Biol Chem; 2001 Apr; 276(17):14324-8. PubMed ID: 11152454
[TBL] [Abstract][Full Text] [Related]
19. [Biology of non-conventional transmissible agents or prions].
Dormont D
Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
[TBL] [Abstract][Full Text] [Related]
20. Prion detection by an amyloid seeding assay.
Colby DW; Zhang Q; Wang S; Groth D; Legname G; Riesner D; Prusiner SB
Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20914-9. PubMed ID: 18096717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
